Wyeth is one of the world’s leading research-driven pharmaceutical companies with a major focus on developing innovative new medicines to improve health and well being.

In the UK, Wyeth offers products across a wide range of treatment areas, including infectious disease, rheumatology, dermatology, palliative care, mental health, women’s healthcare, gastro-intestinal disease, haemophilia, oncology, transplantation, and vaccination.

In the field of infectious disease, a key focus for us is to build strong relationships with our NHS customers – relationships based on trust and integrity, which genuinely support health improvement.

www.wyeth.co.uk

Merck Sharp & Dohme Limited (MSD) is the UK subsidiary of Merck & Co., Inc., of Whitehouse Station, New Jersey, USA, a leading research-based pharmaceutical company that discovers, develops, manufactures and markets a wide range of innovative pharmaceutical products to improve human health.

www.msd-uk.co.uk

Eumedica Pharmaceuticals, a different partnership to the hospital environment, seeks to ensure the development & continuity of vital treatment in serious indications:

Negaban® temocillin, a 6-α methoxy penicillin derivative (β-lactam), has a sustained profile of susceptibility, more than a decade after its introduction into daily clinical practice.

Negaban® temocillin, a narrow spectrum directed towards gram-negative bacteria with a proven stability against all types of β-lactamases, including ESBLs and AmpCs.

www.eumedica.com/